Tixagevimab plus Cilgavimab: First Approval

Keam, SJ

Keam, SJ (通讯作者),Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2022; 82 (9): 1001

Abstract

Tixagevimab 150 mg and cilgavimab 150 mg (EVUSHELD (TM) 150 mg + 150 mg solution for injection; tixagevimab + cilgavimab) is an intramuscular (IM) lon......

Full Text Link